scispace - formally typeset
C

Cong Chen

Researcher at Sir Run Run Shaw Hospital

Publications -  27
Citations -  899

Cong Chen is an academic researcher from Sir Run Run Shaw Hospital. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 9, co-authored 17 publications receiving 383 citations. Previous affiliations of Cong Chen include Zhejiang University.

Papers
More filters
Journal ArticleDOI

Exosome: emerging biomarker in breast cancer

TL;DR: The current knowledge and concepts concerning the exosomes involvement in breast cancer pathogenesis (including tumor initiation, invasion and metastasis, angiogenesis, immune system modulation and tumor microenvironment) and cancer therapy resistance are outlined.
Journal ArticleDOI

The long noncoding RNA H19 promotes tamoxifen resistance in breast cancer via autophagy.

TL;DR: It is demonstrated that H19 induces autophagy activation via the H19/SAHH/DNMT3B axis, which could contribute to tamoxifen resistance in breast cancer.
Journal ArticleDOI

Glucose transporter GLUT1 expression and clinical outcome in solid tumors: a systematic review and meta-analysis

TL;DR: Overexpression of GLUT1 was found to significantly correlate with poor 3-year OS and 5-year survival in most solid tumors, suggesting that the expression status ofGLUT1 is a vital prognostic indicator and promising therapeutic target in solid tumors.
Journal ArticleDOI

Metformin induces Ferroptosis by inhibiting UFMylation of SLC7A11 in breast cancer.

TL;DR: This study is the first to demonstrate that the ability of metformin to induce ferroptosis may be a novel mechanism underlying its anti-cancer effect, and identified SLC7A11 as a new UFMylation substrate and found that targeting the UFM1/SLC 7A11 pathway could be a promising cancer treatment strategy.
Journal ArticleDOI

Targeting ferroptosis in breast cancer

TL;DR: It is proposed that viewing ferroPTosis-related studies from a historical angle will accelerate the development of ferroptosis-based biomarkers and therapeutic strategies in breast cancer.